Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03508765 : Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation
PhaseN/A
AgesMin: 60 Years Max: 75 Years
Eligibility
Inclusion Criteria:

- Diagnosed with multiple myeloma and in complete, partial or very good partial
remission at enrollment as per standard International Myeloma Working Group Criteria

- Scheduled to have high-dose chemotherapy and ASCT

- Age 60 - 75 years at study entry

- In the judgment of the consenting professional, fluent and able to communicate well
enough in English to complete the study assessments and provide informed consent.

- Patients who report that English is not their primary language will be asked the
US Census English proficiency question "How well do you speak English" and the
answer "very well" will be required

Exclusion Criteria:

- With signs and/or symptoms of central nervous system cancers (e.g., tumors,
metastases, leptomeningial disease) as determined by their physician, medical records,
or by a brain MRI, either at the time of enrollment or during the study period

- With current diagnosis of major Axis I psychiatric disorder (DSM-IV), major
depression, bipolar disorder, or schizophrenia, as per medical records or patient
report

- As per patient report or as confirmed by the medical record, if the patient is taking
anti-depression or anti-anxiety medication, < 2 months on these medications or a
change in the prescribed dose in the past 2 months

- With history of a neurological disorder, neurodegenerative disease, or traumatic brain
injury with loss of consciousness (>60 minutes), as per medical records or patient
report

- With a history of another cancer, except for non-melanoma skin cancer, as per medical
records or patient report

- With current substance abuse and/or history of substance abuse, as per medical records
or patient report

- With evidence of visual or auditory impairment that would preclude completion of the
assessments, as per medical records or patient report

- With contraindications to MRI examinations as per standard screening guidelines used
in the Department of Radiology (i.e., ferromagnetic material or implants, pacemakers
or defibrillators, stents, claustrophobia)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03508765      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740